News
On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...
Amphastar Pharmaceuticals (AMPH) upgraded to Buy by Needham after FDA approval for generic iron sucrose injection, marking ...
US generics major Viatris has won US Food and Drug Administration (FDA) approval for iron sucrose injection, USP, an ...
Viatris receives US FDA approval for generic iron sucrose injection to treat IDA in chronic kidney disease: Pittsburgh Tuesday, August 12, 2025, 18:00 Hrs [IST] Viatris Inc., a gl ...
TipRanks on MSN21h
Amphastar announced FDA approval of iron sucrose injection
Pharmaceuticals announced yesterday morning that the Food and Drug Administration approved the company’s abbreviated new drug ...
TipRanks on MSN21h
Needham upgrades Amphastar on valuation post AMP-002 approval
Needham upgraded Amphastar (AMPH) (APMH) to Buy from Hold with a $36 price target. The company’s AMP-002 is an iron sucrose injection product that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback